287
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia*

&
Pages 2741-2749 | Accepted 25 Jul 2008, Published online: 19 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Onur Baser, Wenhui Wei, Erdem Baser & Lin Xie. (2011) Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID. Journal of Medical Economics 14:6, pages 673-680.
Read now
Estella M Davis, Emily L Sexson, Mikayla L Spangler & Pamela A Foral. (2010) An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®. Medical Devices: Evidence and Research 3, pages 41-50.
Read now

Articles from other publishers (14)

Mei-Chuan Huang, Chich-Hsiu Hung, Ching-Yun Yu, Diane C. Berry, Shyi-Jang Shin & Yu-Yun Hsu. (2017) The effectiveness of multimedia education for patients with type 2 diabetes mellitus. Journal of Advanced Nursing 73:4, pages 943-954.
Crossref
Wojciech FendlerDanuta Roman-LiuTomasz TokarskiRadoslaw RomanczukWojciech Mlynarski. (2015) Trigger Matters: An Ergonomy Analysis of Insulin Pens. Diabetes Technology & Therapeutics 17:3, pages 171-176.
Crossref
Stacey A. Seggelke, R. Matthew Hawkins, Joanna Gibbs, Neda Rasouli, Cecilia C. Low Wang & Boris Draznin. (2014) Effect of Glargine Insulin Delivery Method (Pen Device Versus Vial/Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes. Endocrine Practice 20:6, pages 536-539.
Crossref
Andrew AhmannSheryl L. SzeinbachJasvinder GillLouise TraylorSatish K. Garg. (2014) Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 16:2, pages 76-83.
Crossref
Robert M. Cuddihy & Sarah K. Borgman. (2013) Considerations for Diabetes. American Journal of Therapeutics 20:6, pages 694-702.
Crossref
Estella M. DavisPamela A. ForalRyan B. DullApril N. Smith. (2013) Review of Insulin Therapy and Pen Use in Hospitalized Patients. Hospital Pharmacy 48:5, pages 396-405.
Crossref
Lin XieSteve ZhouWenhui WeiJasvinder GillChunshen PanOnur Baser. (2013) Does Pen Help? A Real-World Outcomes Study of Switching from Vial to Disposable Pen Among Insulin Glargine-Treated Patients with Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics 15:3, pages 230-236.
Crossref
Nicolae Hancu, Leszek Czupryniak, Elisabeth Genestin & Harald Sourij. (2011) A Pan-European and Canadian Prospective Survey to Evaluate Patient Satisfaction with the SoloSTAR Insulin Injection Device in Type 1 and Type 2 Diabetes. Journal of Diabetes Science and Technology 5:5, pages 1224-1234.
Crossref
Thomas van der Burg. (2011) Injection Force of SoloSTAR® Compared with other Disposable Insulin Pen Devices at Constant Volume Flow Rates. Journal of Diabetes Science and Technology 5:1, pages 150-155.
Crossref
Mark Lefkowitz. (2011) Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long-Acting versus Short-Acting Insulins?. Journal of Diabetes Science and Technology 5:1, pages 136-149.
Crossref
Judith Hey-Hadavi, Andreas Pleil, Larry C. Deeb, John S. Fuqua, Lawrence A. Silverman, Barry Reiner, Ron Newfield, Natasa Rajicic, Michael P. Wajnrajch & Jose F. Cara. (2010) Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-Month, single-arm, open-label clinical trial in patient-caregiver dyads. Clinical Therapeutics 32:12, pages 2036-2047.
Crossref
Riccardo Perfetti. (2010) Reusable and Disposable Insulin Pens for the Treatment of Diabetes: Understanding the Global Differences in User Preference and an Evaluation of Inpatient Insulin Pen Use. Diabetes Technology & Therapeutics 12:S1, pages S-79-S-85.
Crossref
John Carter, Jonathan Beilin, Adam Morton & Mario De Luise. (2009) Usability, Participant Acceptance, and Safety of a Prefilled Insulin Injection Device in a 3-Month Observational Survey in Everyday Clinical Practice in Australia. Journal of Diabetes Science and Technology 3:6, pages 1425-1438.
Crossref
Arnd Friedrichs. (2009) Dose Accuracy of SoloSTAR and FlexPen as Assessed in a Clinical Setting. Diabetes Technology & Therapeutics 11:9, pages 609-613.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.